Every Form 4 that The Scotts Miracle-Gro Company (SMG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow SMG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SMG filings page.
SCOTTS MIRACLE-GRO CO executive Christopher Hagedorn, EVP & Chief of Staff, reported a small internal share restructuring. A Form 4 entry coded as an “other” transaction (J) covered 3.969 Common Shares at $54.67 per share, leaving him with 57,535.3424 directly held shares.
Scheiwer Mark J reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO executive Mark J. Scheiwer reported routine equity-related updates. As EVP, CFO & CAO, he received a grant of 11.037 Phantom Stock units at $67.95 per unit, each representing the right to one common share or its cash value.
These phantom stock units are payable in cash after his employment ends, and he may move them into alternative investments at any time. Following this award, his phantom stock balance is 1,365.84 units. A separate code J entry shows 2.744 Common Shares at $54.67, with total direct common share holdings of 15,375.186 shares, plus 493.482 shares held indirectly through a 401(k) plan.
HAGEDORN JAMES reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO Chairman & CEO James Hagedorn received a grant of 1,226.377 phantom stock units on Common Shares at $67.95 per unit. These phantom stock units are payable in cash after his employment ends and each represents the value of one common share or its cash equivalent.
He also reported a small other transaction involving 36.583 Common Shares, leaving 88,591.5658 Common Shares held directly. Indirectly, he has a proportionate interest in 997,910 Common Shares through Hagedorn Partnership, L.P. and 31,533.6400 Common Shares through a 401(k) plan.
Johnson Stephen L reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro director Stephen L. Johnson corrected a previously reported stock award. An earlier Form 4 accidentally left out a grant of 6 Common Shares issued under a board retainer deferral election. As clarified, he actually received 118 Common Shares instead of the 112 originally reported, and now holds 31,245 Common Shares directly.
Sandoval Brian E reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO director Brian E. Sandoval reported receiving a grant of 472 Common Shares on April 1, 2026 at a price of $61.01 per share. After this compensation-related award, he directly owns 19,195 Common Shares of the company.
Johnson Stephen L reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro director Stephen L. Johnson received a stock-based retainer grant valued at $7,188. He was awarded 112 Common Shares on the form’s reported date at a reference price of $61.01 per share, issued as Deferred Stock Units in lieu of a cash retainer. Following this grant, Johnson directly holds 31,239 Common Shares, so the award represents a small addition to his existing ownership and reflects routine director compensation rather than an open-market purchase.
Scotts Miracle-Gro Chairman & CEO James Hagedorn settled compensation-related phantom stock into common shares in a routine transaction. On March 30, 2026, he exercised 1,720.158 phantom stock units, receiving an equal number of common shares at a conversion price of $0.00 per share.
Of the resulting 1,720 common shares, 637 shares were withheld at $60.202 per share to cover tax obligations, a non-market “F” code tax-withholding disposition. After these transactions, he directly holds 88,554.9828 common shares and 238,673.3600 phantom stock units, indicating a primarily administrative change in how his compensation is held.
Scheiwer Mark J reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro EVP, CFO & CAO Mark J. Scheiwer received a grant of 124.104 shares of phantom stock on common shares of the company. Following this award, his reported phantom stock balance is 1,354.803 shares.
Each phantom stock share represents the right to receive one common share of Scotts Miracle-Gro or the cash value of that share. These phantom shares are payable in cash after his employment with the company ends, and he may transfer the phantom stock into an alternative investment at any time.
HAGEDORN JAMES reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro Chairman & CEO James Hagedorn received a grant of 3,000.370 phantom stock units tied to common shares. The grant is valued at $65.11 per unit and increases his phantom stock holdings to 240,393.518 units. Each phantom unit represents the right to receive one common share or its cash value, generally payable in cash after his employment with the company ends.
Miaritis Nick reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro director Nick Miaritis reported an equity-related award rather than an open-market trade. He received 64 dividend equivalent rights on March 6, 2026, at a price of $0.00 per right, bringing his directly held dividend equivalent rights to 194.
The filing explains these dividend equivalent rights accrue on deferred or restricted stock units and become exercisable in step with those underlying awards. Each right is described as economically equivalent to one common share of Scotts Miracle-Gro, aligning the director’s compensation more closely with shareholder returns.
Miller Austin Scott reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro director Austin Scott Miller received an equity-linked award of 48 dividend equivalent rights. These rights were granted at a price of $0.00 per right and increase his directly held dividend equivalent rights to 81 following the transaction. According to the disclosure, each dividend equivalent right is economically equal to one common share and accrues on DSU or RSU grants, becoming exercisable in step with the underlying DSUs or RSUs.
SCOTTS MIRACLE-GRO CO director David C. Evans received an equity-related award tied to dividends on prior grants. On March 6, he acquired 105 dividend equivalent rights at a stated price of $0.00 per right. These rights accrue on DSU or RSU grants and become exercisable proportionately with the underlying awards, with each right economically equivalent to one common share. Following this award, Evans directly holds 552 dividend equivalent rights.
Scheiwer Mark J reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro executive Mark J. Scheiwer, EVP, CFO & CAO, reported several equity-related transactions. He received 12.378 shares of phantom stock, each representing the right to one common share or its cash value, and now holds 1,230.699 phantom stock shares.
He was also granted 42 dividend equivalent rights, economically equal to common shares and tied to prior DSU or RSU grants, bringing his total dividend equivalent rights to 405. In a separate transaction coded "J" on common shares, he recorded 2.701 common shares at 55.5400 per share, with direct ownership rising to 15,372.442 shares.
Additionally, he indirectly holds 493.482 common shares through a 401(k) plan. Phantom stock is payable in cash after his employment ends, and he may transfer it into alternative investments at any time.
SCOTTS MIRACLE-GRO CO director Peter E. Shumlin received a grant of 153 Dividend Equivalent Rights on the company’s stock. The award was reported at a price of $0.0000 per right and is classified as a grant or other acquisition. Following this transaction, his directly held Dividend Equivalent Rights total 845. According to the disclosure, these rights accrue on DSU or RSU grants and become exercisable proportionately with the underlying DSUs or RSUs, with each right economically equivalent to one common share.
Aviles Edith reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro director Edith Aviles received a grant of 105 dividend equivalent rights tied to existing equity awards. These derivative rights were awarded at a price of $0.00 per right and increase her directly held derivative position to 552 rights.
The dividend equivalent rights accrue on deferred or restricted stock units and become exercisable proportionately with those underlying units. Each right is described as economically equivalent to one common share of Scotts Miracle-Gro, giving the holder the same cash value as regular share dividends when paid.
Scotts Miracle-Gro president and COO Nathan Eric Baxter reported an administrative change in his holdings of the company’s common shares. The Form 4 lists an “other transaction” involving 90.025 common shares at $55.54 per share, after which his directly held stake is shown as 66,722.4238 common shares.
The filing also updates indirect ownership information. It notes 36,993 common shares held through Hagedorn Partnership, L.P., a Delaware limited partnership where Baxter is a general partner. Under securities rules, he may be deemed a beneficial owner of a proportionate interest in those partnership-held shares.
Kingdon Mark D reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO director Mark D. Kingdon reported an award of 105 Dividend Equivalent Rights on common shares. These rights accrued on DSU or RSU grants at a price of $0.0000 per right, bringing his directly held Dividend Equivalent Rights to 552 following the transaction.
Each Dividend Equivalent Right is the economic equivalent of one common share and becomes exercisable proportionately with the related DSUs or RSUs.
Scotts Miracle-Gro Co director and major shareholder Katherine Littlefield Hagedorn reported an award of derivative securities tied to the company’s common stock. On the reported date, she acquired 33 dividend equivalent rights at a price of $0.00 per right, bringing her holdings of these rights to 33.
According to the disclosure, these dividend equivalent rights accrue on deferred or restricted stock unit grants and become exercisable in step with the underlying DSUs or RSUs. Each right is described as being economically equivalent to one common share of Scotts Miracle-Gro.
Scotts Miracle-Gro director Roberto Candelino reported an equity-related award. On March 6, 2026, he acquired 68 dividend equivalent rights at a price of $0.0000 per right, bringing his holdings in these instruments to 218 rights.
The footnote explains that these dividend equivalent rights accrue on DSU or RSU grants and become exercisable in step with the underlying DSUs or RSUs. Each right is described as the economic equivalent of one common share of Scotts Miracle-Gro, aligning the director’s compensation with shareholder outcomes.
Scotts Miracle-Gro executive Christopher Hagedorn reported a small change in his common share holdings. On February 27, 2026, a Form 4 lists an “other” type transaction involving 3.907 common shares at $55.54 per share. Following this adjustment, his directly owned stake stands at 57,531.3734 common shares.
SCOTTS MIRACLE-GRO CO Chairman & CEO James Hagedorn reported new equity-related activity. On March 6, 2026 he acquired 2,396.642 phantom stock units at $0 per unit, increasing his phantom stock balance to 237,393.148 units.
Each phantom stock unit represents the right to receive one common share of Scotts Miracle-Gro or its cash value and is payable in cash after his employment ends. He also reported indirect holdings of 31,533.640 common shares through a 401(k) plan and a proportionate interest in 997,910 common shares held by Hagedorn Partnership, L.P. A separate J-code transaction on February 27, 2026 involved 36.010 directly held common shares at $55.54 per share, leaving him with 87,471.9828 directly held common shares.
Scotts Miracle-Gro director Adam Hanft reported an equity-based compensation award. On March 6, 2026, he acquired 105 Dividend Equivalent Rights at a price of $0.00 per right as a grant or award. Following this transaction, he holds 552 Dividend Equivalent Rights directly. According to the disclosure, these rights accrue on DSU or RSU grants and become exercisable proportionately with those units, and each right is the economic equivalent of one common share of Scotts Miracle-Gro.
Johnson Stephen L reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro director Stephen L. Johnson received a grant of 138 Dividend Equivalent Rights on March 6, 2026. These rights were awarded at a price of $0.00 per right as a form of derivative-based compensation.
The dividend equivalent rights accrue on DSU or RSU grants and become exercisable proportionately with the DSUs or RSUs they relate to. Each right is the economic equivalent of one common share of Scotts Miracle-Gro. Following this award, Johnson directly holds a total of 750 Dividend Equivalent Rights.
Sandoval Brian E reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO director Brian E. Sandoval received an equity-related award. On the reported date, he was granted 151 dividend equivalent rights tied to existing deferred or restricted stock unit grants, at a stated price of $0 per right. Following this award, he holds 787 dividend equivalent rights, each economically equivalent to one common share.
Scheiwer Mark J reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO executive Mark J. Scheiwer, EVP, CFO & CAO, reported receiving a grant of 10.748 units of phantom stock on February 26, 2026. The award is recorded at a reference price of $69.78 per unit and is classified as a derivative security.
Each phantom stock unit represents the right to receive one common share of the company or the cash value of that share. The phantom stock is payable in cash after Scheiwer’s employment with the company ends, and he may move these units into an alternative investment at any time. Following this grant, he holds a total of 1,218.321 phantom stock units directly.
Scotts Miracle-Gro Chairman and CEO James Hagedorn reported an acquisition of phantom stock under an incentive arrangement. He was granted 1,194.235 phantom stock units at a reference price of $69.78 per unit, increasing his directly held phantom stock balance to 234,996.506 units.
Each phantom stock unit represents the right to receive one common share of Scotts Miracle-Gro or its cash value. According to the terms, the phantom stock is payable in cash after his employment with the company ends, and he may transfer these units into an alternative investment at any time.
SCOTTS MIRACLE-GRO CO executive Mark J. Scheiwer, EVP, CFO & CAO, purchased 693 common shares in an open-market transaction at a price of $71.435 per share. After this purchase, he directly owned 15,369.741 common shares, with an additional 493.482 shares held indirectly through a 401(k) plan.
Hagedorn Partnership, L.P., a director and 10% owner of Scotts Miracle-Gro, reported an open-market sale of common shares. On 02/12/2026, the partnership sold 50,000 common shares at a weighted average price of $66.3987 per share, with trades ranging from $65.98 to $66.64. After this transaction, it beneficially owned 13,167,641 common shares directly.
Scotts Miracle-Gro director Adam Hanft reported a routine equity award conversion. On February 3, 2026, he exercised dividend equivalent rights tied to restricted stock units, converting 336 Dividend Equivalent Rights into 336 Common Shares at a price of $0 per share. Following the transaction, he beneficially owned 45,018 Common Shares directly and 447 Dividend Equivalent Rights. The footnotes explain that restricted stock units convert into common shares on a one-for-one basis and reference a prior grant of 2,553 restricted stock units awarded on February 3, 2023 with vesting on February 3, 2024.
Scotts Miracle-Gro director Mark D. Kingdon reported an equity award transaction. On February 3, 2026, restricted stock units converted into 165 common shares at a price of $0, reflecting a vesting-related acquisition rather than an open-market purchase.
Following this transaction, Kingdon directly owns 11,658 common shares and 447 dividend equivalent rights. The filing notes that restricted stock units convert into common shares on a one-for-one basis and that he had been granted 1,497 restricted stock units with accruing dividend equivalent rights on July 13, 2023, vesting on February 3, 2024.
Scotts Miracle-Gro Chairman and CEO James Hagedorn reported a disposition of 16,677 Common Shares of SCOTTS MIRACLE-GRO on February 3, 2026 at $63.69 per share under transaction code F. After this transaction, he directly holds 87,435.9728 Common Shares.
He also reports indirect holdings of 31,533.64 Common Shares through a 401(k) plan and 997,910 Common Shares indirectly through Hagedorn Partnership, L.P. The filing states he may be deemed a more than 10% beneficial owner based on his proportionate interest in this partnership.
Scotts Miracle-Gro executive Christopher Hagedorn reported a small share disposition. On 02/03/2026, a Form 4 filing shows 2,588 common shares of Scotts Miracle-Gro were disposed of at a price of $63.69 per share. Following this transaction, Hagedorn directly owned 57,527.4664 common shares of the company.
Scotts Miracle-Gro director David C. Evans reported a stock-based award conversion. On February 3, 2026, 336 common shares of Scotts Miracle-Gro were acquired at a price of $0 per share following the exercise of dividend equivalent rights tied to prior restricted stock unit awards.
After this transaction, Evans directly owned 28,060 common shares and 447 dividend equivalent rights. The filing reflects routine equity compensation activity, where previously granted restricted stock units and associated dividend equivalents convert into common shares on a one-for-one basis.
Scotts Miracle-Gro director Stephen L. Johnson reported acquiring 336 common shares on February 3, 2026 at no cost through the settlement of dividend equivalent rights tied to prior equity awards. After this transaction, he directly owns 31,127 common shares and 612 dividend equivalent rights.
Scotts Miracle-Gro executive Dimiter Todorov reported a disposition of company stock. On February 3, 2026, he reported the disposition of 2,254 common shares of Scotts Miracle-Gro at $63.69 per share. Following this transaction, he directly beneficially owned 19,014 common shares.
Todorov is an officer of Scotts Miracle-Gro, serving as EVP, CLO & Corporate Secretary, and filed this report as a single reporting person.
Scotts Miracle-Gro director Edith Aviles reported a share acquisition tied to equity awards. On February 3, 2026, 336 restricted stock units converted into 336 common shares at a price of $0 per share, reflecting a vesting event rather than an open-market purchase.
The filing also shows a related transaction in 336 dividend equivalent rights, which are linked to the same underlying common shares. After these transactions, Aviles directly holds 14,304 common shares and 447 dividend equivalent rights in Scotts Miracle-Gro.
Scotts Miracle-Gro executive Mark J. Scheiwer, EVP, CFO & CAO, reported an insider transaction involving company common shares. On 02/03/2026, he disposed of 612 common shares at $63.69 per share (transaction code F), a form of non-derivative disposition.
Following this transaction, Scheiwer directly beneficially owned 14,676.741 common shares. He also indirectly held an additional 493.482 common shares through a 401(k) plan, reflecting his retirement-plan stake in the company’s stock.
Scotts Miracle-Gro director Brian E. Sandoval reported the conversion of equity awards into common shares. On February 3, 2026, 336 dividend equivalent rights were exercised at $0 and delivered as 336 common shares.
Following this transaction, Sandoval directly held 18,723 common shares of Scotts Miracle-Gro and 636 dividend equivalent rights. The filing notes that restricted stock units convert into common shares on a one-for-one basis and references a prior grant of 2,553 restricted stock units with accruing dividend equivalent rights.
Scotts Miracle-Gro director Peter E. Shumlin reported an automatic conversion of 336 dividend equivalent rights into 336 common shares on February 3, 2026, at an exercise price of $0.
Following this transaction, he directly held 30,846 common shares and 692 dividend equivalent rights.
Scotts Miracle-Gro director Roberto Candelino reported acquiring additional company stock. On 01/30/2026, he acquired 3,271 Common Shares at a reported price of $0 per share, likely reflecting a no-cash equity award. After this transaction, he beneficially owned 6,614 Common Shares, held directly.
Scotts Miracle-Gro director Edith Aviles acquired 3,271 common shares on January 30, 2026 at a reported price of $0 per share. After this transaction, she directly beneficially owns 13,968 common shares of the company.
Scotts Miracle-Gro executive Christopher Hagedorn reported new equity awards and a minor share transaction. He received a stock option grant for 29,649 common shares at an exercise price of $64.22 per share, with the option expiring on 01/30/2036. The option covers 29,649 underlying common shares and is held directly.
He also reported an acquisition coded "J" of 4.179 common shares at a price of $51.93 per share. Following this transaction, he directly beneficially owned 60,115.4664 common shares of Scotts Miracle-Gro.
Scotts Miracle-Gro director Katherine Hagedorn Littlefield reported receiving 3,271 Common Shares of the company on January 30, 2026. The shares were acquired at a reported price of $0 per share, indicating a grant or similar no-cost award.
After this transaction, she directly holds 10,211 Common Shares. She is also reported as having an indirect interest in 2,774,291 Common Shares held by Hagedorn Partnership, L.P., reflecting her proportionate interest and that of certain family members in the partnership’s holdings.
The Scotts Miracle-Gro Company director reports new share award. Director David C. Evans acquired 3,271 common shares of Scotts Miracle-Gro on January 30, 2026 in a transaction reported at $0 per share, indicating a grant or award rather than an open-market purchase. After this transaction, he beneficially owns 27,724 common shares, held directly.
Scotts Miracle-Gro director Austin Scott Miller acquired additional company shares. On 01/30/2026, he acquired 3,271 common shares at a price of $0 per share, increasing his direct holdings to 4,686 common shares.
Scotts Miracle-Gro director Nick Miaritis reported receiving 3,271 common shares on January 30, 2026, at a stated price of $0 per share. After this acquisition, he beneficially owned 6,231 common shares, held directly. The transaction was reported on a Form 4 insider trading report.
Scotts Miracle-Gro director Adam Hanft reported acquiring 3,271 common shares of the company on January 30, 2026. The shares were acquired at a reported price of $0 per share, which typically indicates a stock grant or award rather than an open-market purchase. Following this transaction, Hanft directly beneficially owns 44,682 common shares of Scotts Miracle-Gro.
Scotts Miracle-Gro President and COO Nathan Eric Baxter, who is also reported as a more than 10% owner, reported new equity awards and updated holdings. On January 30, 2026, he received a stock option for 59,298 common shares at an exercise price of $64.22 per share, expiring between January 30, 2029 and January 30, 2036.
The filing also shows a transaction coded "J" for 96.284 common shares at a price of $51.93 per share, after which Baxter directly held 66,632.3988 common shares. In addition, 36,993 common shares are reported as indirectly owned through Hagedorn Partnership, L.P., where he is a general partner and may be deemed to have a proportionate beneficial interest under the SEC’s Rule 16a-1(a)(1).
Scotts Miracle-Gro director Peter E. Shumlin reported stock-based awards and conversions. On 01/30/2026, he acquired 4,049 common shares at $0, bringing his direct holdings to 30,328 shares. On 02/02/2026, 182 dividend equivalent rights were converted at $0 into 182 common shares, increasing his direct ownership to 30,510 shares.
The 182-share conversion came from dividend equivalent rights tied to a grant of 1,398 restricted stock units awarded on February 3, 2023, which vest on February 2, 2026. After this transaction, 1,028 dividend equivalent rights remain outstanding.
Scotts Miracle-Gro EVP, CFO & CAO Mark J. Scheiwer reported new equity awards and updated share holdings. On January 30, 2026, he received 29,649 stock options with an exercise price of $64.22 per common share, all held directly. The same day, he acquired 2.888 common shares at $51.93 each, bringing his directly held common shares to 15,288.741. He also reported indirect ownership of 493.482 common shares through a 401(k) plan.